
### [MONDO:0018363](http://purl.obolibrary.org/obo/MONDO_0018363)
**Label:** focal facial dermal dysplasia

**Subclasses:** [MONDO:0009203](http://purl.obolibrary.org/obo/MONDO_0009203) (focal facial dermal dysplasia type III), [MONDO:0013996](http://purl.obolibrary.org/obo/MONDO_0013996) (focal facial dermal dysplasia type II), [MONDO:0007627](http://purl.obolibrary.org/obo/MONDO_0007627) (focal facial dermal dysplasia type I), [MONDO:0013997](http://purl.obolibrary.org/obo/MONDO_0013997) (focal facial dermal dysplasia type IV), 

**Mapped go classes:** [GO:0009952](http://purl.obolibrary.org/obo/GO_0009952) (anterior/posterior pattern specification), [GO:0042573](http://purl.obolibrary.org/obo/GO_0042573) (retinoic acid metabolic process), [GO:0060325](http://purl.obolibrary.org/obo/GO_0060325) (face morphogenesis), [GO:0005667](http://purl.obolibrary.org/obo/GO_0005667) (transcription factor complex), [GO:0043392](http://purl.obolibrary.org/obo/GO_0043392) (negative regulation of DNA binding), [GO:0001076](http://purl.obolibrary.org/obo/GO_0001076) (transcription factor activity, RNA polymerase II transcription factor binding), [GO:0048284](http://purl.obolibrary.org/obo/GO_0048284) (organelle fusion), [GO:0045892](http://purl.obolibrary.org/obo/GO_0045892) (negative regulation of transcription, DNA-templated), [GO:0005506](http://purl.obolibrary.org/obo/GO_0005506) (iron ion binding), [GO:0016491](http://purl.obolibrary.org/obo/GO_0016491) (oxidoreductase activity), [GO:0030902](http://purl.obolibrary.org/obo/GO_0030902) (hindbrain development), [GO:0001944](http://purl.obolibrary.org/obo/GO_0001944) (vasculature development), [GO:0033339](http://purl.obolibrary.org/obo/GO_0033339) (pectoral fin development), [GO:0032720](http://purl.obolibrary.org/obo/GO_0032720) (negative regulation of tumor necrosis factor production), [GO:0019904](http://purl.obolibrary.org/obo/GO_0019904) (protein domain specific binding), [GO:0014032](http://purl.obolibrary.org/obo/GO_0014032) (neural crest cell development), [GO:0046983](http://purl.obolibrary.org/obo/GO_0046983) (protein dimerization activity), [GO:0021661](http://purl.obolibrary.org/obo/GO_0021661) (rhombomere 4 morphogenesis), [GO:0005634](http://purl.obolibrary.org/obo/GO_0005634) (nucleus), [GO:0005515](http://purl.obolibrary.org/obo/GO_0005515) (protein binding), [GO:0007417](http://purl.obolibrary.org/obo/GO_0007417) (central nervous system development), [GO:0046872](http://purl.obolibrary.org/obo/GO_0046872) (metal ion binding), [GO:0055014](http://purl.obolibrary.org/obo/GO_0055014) (atrial cardiac muscle cell development), [GO:0034653](http://purl.obolibrary.org/obo/GO_0034653) (retinoic acid catabolic process), [GO:0016125](http://purl.obolibrary.org/obo/GO_0016125) (sterol metabolic process), [GO:0044092](http://purl.obolibrary.org/obo/GO_0044092) (negative regulation of molecular function), [GO:0007275](http://purl.obolibrary.org/obo/GO_0007275) (multicellular organism development), [GO:0016705](http://purl.obolibrary.org/obo/GO_0016705) (oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen), [GO:0008285](http://purl.obolibrary.org/obo/GO_0008285) (negative regulation of cell proliferation), [GO:0008401](http://purl.obolibrary.org/obo/GO_0008401) (retinoic acid 4-hydroxylase activity), [GO:0003151](http://purl.obolibrary.org/obo/GO_0003151) (outflow tract morphogenesis), [GO:0005730](http://purl.obolibrary.org/obo/GO_0005730) (nucleolus), [GO:0045668](http://purl.obolibrary.org/obo/GO_0045668) (negative regulation of osteoblast differentiation), [GO:0000122](http://purl.obolibrary.org/obo/GO_0000122) (negative regulation of transcription by RNA polymerase II), [GO:0010838](http://purl.obolibrary.org/obo/GO_0010838) (positive regulation of keratinocyte proliferation), [GO:0003700](http://purl.obolibrary.org/obo/GO_0003700) (DNA binding transcription factor activity), [GO:0001649](http://purl.obolibrary.org/obo/GO_0001649) (osteoblast differentiation), [GO:0045638](http://purl.obolibrary.org/obo/GO_0045638) (negative regulation of myeloid cell differentiation), [GO:0006351](http://purl.obolibrary.org/obo/GO_0006351) (transcription, DNA-templated), [GO:0048701](http://purl.obolibrary.org/obo/GO_0048701) (embryonic cranial skeleton morphogenesis), [GO:0006355](http://purl.obolibrary.org/obo/GO_0006355) (regulation of transcription, DNA-templated), [GO:0003682](http://purl.obolibrary.org/obo/GO_0003682) (chromatin binding), [GO:0061303](http://purl.obolibrary.org/obo/GO_0061303) (cornea development in camera-type eye), [GO:0004497](http://purl.obolibrary.org/obo/GO_0004497) (monooxygenase activity), [GO:0006357](http://purl.obolibrary.org/obo/GO_0006357) (regulation of transcription by RNA polymerase II), [GO:0020037](http://purl.obolibrary.org/obo/GO_0020037) (heme binding), [GO:0003677](http://purl.obolibrary.org/obo/GO_0003677) (DNA binding), [GO:0001972](http://purl.obolibrary.org/obo/GO_0001972) (retinoic acid binding), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0043066](http://purl.obolibrary.org/obo/GO_0043066) (negative regulation of apoptotic process), [GO:0030154](http://purl.obolibrary.org/obo/GO_0030154) (cell differentiation), [GO:0055114](http://purl.obolibrary.org/obo/GO_0055114) (oxidation-reduction process), 

**Class expressions from DL-Learner:**

- [GO:1903556](http://purl.obolibrary.org/obo/GO_1903556) (negative regulation of tumor necrosis factor superfamily cytokine production) 52.94%
- [GO:0060325](http://purl.obolibrary.org/obo/GO_0060325) (face morphogenesis) 52.94%
- [GO:0055014](http://purl.obolibrary.org/obo/GO_0055014) (atrial cardiac muscle cell development) 52.94%
- [GO:0048705](http://purl.obolibrary.org/obo/GO_0048705) (skeletal system morphogenesis) 52.94%
- [GO:0048704](http://purl.obolibrary.org/obo/GO_0048704) (embryonic skeletal system morphogenesis) 52.94%
- [GO:0048701](http://purl.obolibrary.org/obo/GO_0048701) (embryonic cranial skeleton morphogenesis) 52.94%
- [GO:0045668](http://purl.obolibrary.org/obo/GO_0045668) (negative regulation of osteoblast differentiation) 52.94%
- [GO:0042573](http://purl.obolibrary.org/obo/GO_0042573) (retinoic acid metabolic process) 52.94%
- [GO:0034653](http://purl.obolibrary.org/obo/GO_0034653) (retinoic acid catabolic process) 52.94%
- [GO:0033339](http://purl.obolibrary.org/obo/GO_0033339) (pectoral fin development) 52.94%
- [GO:0032720](http://purl.obolibrary.org/obo/GO_0032720) (negative regulation of tumor necrosis factor production) 52.94%
- [GO:0030902](http://purl.obolibrary.org/obo/GO_0030902) (hindbrain development) 52.94%
- [GO:0021661](http://purl.obolibrary.org/obo/GO_0021661) (rhombomere 4 morphogenesis) 52.94%
- [GO:0007417](http://purl.obolibrary.org/obo/GO_0007417) (central nervous system development) 52.94%
- [GO:0003151](http://purl.obolibrary.org/obo/GO_0003151) (outflow tract morphogenesis) 52.94%


